Skip to content
Review Open access

Recurrent Single-Nucleotide Insertions in the Mitochondrial Second Light-Strand Promoter Cause Tubulointerstitial Kidney Disease

Aug 2026 · medRxiv · 0 citations
Medicine

TL;DR

Findings establish the physiological relevance of the LSP2 promoter, support routine assessment of the mitochondrial genome in inherited kidney disease, and highlight mtDNA variants as an important cause of familial and sporadic tubulointerstitial kidney disease of previously unexplained etiology.

Read PDF

Similar papers

Open access Jul 2026

Identification of Nuclear Genetic Loci Linked to Clinical Features of the m.3243A>G Mitochondrial DNA Variant

The value of large, well-characterized patient cohorts in identifying modifier loci and advancing knowledge of the mechanisms underlying phenotypic variability in mtDNA disease is highlighted, as each showed the strongest gene-level signals within the linkage region across complementary burden-testing methods.

R. Boggan, Theodora-Dafni Michalettou, Y. Ng et al. · 0 citations
Open access Aug 2026

Neonatal mitochondrial encephalopathy due to a splice-altering variant in COX16

Two siblings born to consanguineous parents who presented with neonatal hypotonia, respiratory failure, lactic acidosis and early death are described, establishing the pathogenicity of a splice-altering COX16 variant and expanding the genetic and phenotypic spectrum of COX16 -related mitochondrial disease.

Nicolas Geoffre, N. Gueguen, Anne-Sophie Guémann et al. · 0 citations
Open access Jul 2026

Integrated exome and mitochondrial genome sequencing reveals the genetic landscape of primary mitochondrial diseases: findings from a large Tunisian cohort.

The genetic spectrum of a Tunisian pediatric cohort with suspected mitochondrial diseases is described to describe the clinical and genetic spectrum of primary mitochondrial diseases in Tunisia, an underrepresented and admixed population.

Ismail Gouiza, A. Bouzidi, Meriem Hechmi et al. · 0 citations
Review Open access Aug 2026

Decoding the Genetic and Phenotypic Spectrum of MT-TI Mitochondrial Diseases.

D diagnosis requires tissue-informed heteroplasmy assessment integrated with phenotype, maternal family history, and functional evidence, and a staged mechanism involving disturbed transfer RNA processing, structure, stability, or aminoacylation is supported.

En-Chi Yuan, Ning Zhang, Haoyu He et al. · 0 citations
Case report Open access Aug 2026

A Novel SLC25A4 Variant Causing Mitochondrial Dysfunction, Myopathy and Cardiomyopathy: A Functional and Molecular Characterization

The molecular and functional spectrum of SLC25A4-associated disease is expanded and may inform clinical practice, including genetic interventions such as preimplantation genetic diagnosis, premarital genetic screening, targeted genetic counseling, and cascade testing of at-risk family members.

Mazhor Aldosary, Hanan Alqudairy, Nourah Alshalan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.